A previous report demonstrated that RUNX2 acted as an initiator of migration and invasion of the HCC cells in vitro by enhancing the expression of the matrix metalloproteinase 9 (MMP9) [103]. The gene discussed is MMP9; the disease is hepatocellular carcinoma.